Baryon Pharmaceuticals UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2021 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 2,500 |
| 0 |
| 0 |
| 2,500 |
| 2022 |
|---|
| 0 |
| 0 |
| 62,556 |
| -62,556 |
| -41,984 |
| - |
| - |
| -60,056 |
| 66,014 |
| 0 |
| 5,958 |
| 2023 |
|---|
| 73,963 |
| 43,253 |
| 47,686 |
| -47,686 |
| -27,887 |
| -52.46 |
| -64.47 |
| -21,708 |
| 58,830 |
| 0 |
| 37,122 |
Register and
explore Okredo data| 2023 |
|---|
| 73,963 |
| 43,253 |
| 47,686 |
| -47,686 |
| -27,887 |
| -52.46 |
| -64.47 |
| -21,708 |
| 58,830 |
| 0 |
| 37,122 |
Register and
explore Okredo data2023
Turnover (€)
73,963 €
- *
Sales per employee (€)
43,253 €- *
Profit before tax (€)
47,686 €
-24 % *
Net Profit (€)
-47,686 €
24 % *
Profit per employee (€)
-27,887 €34 % *
Total profitability (%)
-52.46 %- *
Net profitability (%)
-64.47 %- *
Equity (€)
-21,708 €64 % *
Amounts Payable And Liabilities (€)
58,830 €
-11 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
37,122 €
523 % *